Answers are grounded in this paper and cite their sources.
Purpose Stimulator of Interferon Genes (STING) is a key inducer of type I interferon signalling that promotes immune cell activation and antitumour immune responses. Reduced STING expression has been reported in multiple tumour types, thus STING agonists are being investigated for their capacity to elicit an anti-tumour immune response, including in triple-negative (TN) breast cancer (BC). However, the role of STING activation within the tumour cells remains largely unexplored. Defining how tumour-intrinsic STING activation influences breast cancer progression and metastasis is critical for the effective therapeutic exploitation of this pathway. Methods We investigated tumour-intrinsic STING expression in breast cancer using phosphorylated STING (pSTING) as a marker of pathway activation. pSTING expression was assessed by immunohistochemistry in two independent cohorts: a breast cancer clinical cohort consisting of 546 BC tumours with > 25 years of clinical follow-up, and a breast cancer to brain metastasis (BrM) cohort consisting of 81 BrM tumours including 50 matched BC-BrM pairs. To define tumour-intrinsic biological programs associated with STING activation, quantitative proteomic profiling was performed following STING overexpression and knockdown in TNBC cells. Results Low or absent pSTING expression in primary tumours was significantly associated with poorer breast cancer–specific survival at both 5 and 30 years ( P = 0.0009, P < 0.001). While pSTING expression was not associated with survival following brain metastasis surgery, patients with pSTING-high primary tumours exhibited a significantly longer time to brain metastasis development ( P = 0.0112). Integrative network and pathway analyses revealed coordinated proteomic reprogramming, including upregulation of ribosomal and translational machinery and suppression of metabolic and epithelial–mesenchymal transition–associated programs. Conclusion Collectively, our findings demonstrate that tumour-intrinsic STING activation is associated with favourable prognosis, delayed brain metastasis development, and coordinated proteomic reprogramming, highlighting a tumour-intrinsic dimension of STING biology beyond immune activation alone.
No takes yet. Share an insight, caveat, or question.
Joshi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: